xcore xtreme l-carnitine 3000 mg L-Carnitine, mg, 20 Fiale, Limone Salute e cura della persona Xtreme L-Carnitine 60 caps

Frontiers in Cardiovascular Medicine 8: 700233

M.BafadhelM.PutchaN

4700-C A HIGH-PERFORMANCE COMPUTING ANALYSIS OF CHOLESTASIS-ASSOCIATED GENE VARIANTS IN PATIENTS WITH CHOLESTASIS PHENOTYPE OF UNCLEAR ETIOLOGY Jonas Schumacher 1 , Toni Herta 1 , Thomas Berg 2 , Frank Lammert 3 , Lutz Brusch 4 , Susanne Weber 5 , Michael Kuecken 4 , Madlen Matz-Soja 1 , Janett Fischer 1 , Markus Casper 5 , Albrecht Bhlig 1 and Irina Lambert 5 , (1)Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany, (2)University Hospital of Leipzig, (3)Medizinische Hochschule Hannover Mhh, Hannover, Germany, (4)Tu Dresden, (5)Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany Background: Heterozygous pathogenic mutations or common polymorphisms in genes encoding the hepatocanalicular transporters ATP8B1 , ABCB11 and ABCB4 , or the bile acid ligand farnesoid X receptor ( FXR ) might contribute to liver injury in patients with an otherwise unexplained cholestasis phenotype

Most will last for at least 10 years

These metabolizing enzymes also play a role in the conversion of valproic acid into inert 4-OH-valproic acid and 5-OH-valproic acid